Menopausal hormone replacement therapy (HRT) has been both praised as a potential longevity drug for women and criticized as a health risk. The ongoing debate centers around the government's recent proposal to remove the black-box warning associated with this therapy, which has raised concerns among health professionals and patients alike. This warning has historically indicated serious risks, leading to a cautious approach to HRT usage. The implications of this proposal could significantly impact women's health management and treatment options.

This week's WSJ Health newsletter covers several significant topics, including a couple who has wagered $300,000 in their quest to have children. It also addresses common misconceptions surrounding antidepressants, highlighting the need for accurate information. Additionally, the newsletter reports on the promising development of the first new malaria drug in years, which could have a substantial impact on malaria treatment and prevention efforts.